This Medical Product Alert relates to a number of confirmed falsified chloroquine products circulating in the WHO region of Africa. Please note that this Medical Product Alert n°4/2020 will be updated as new reports of falsified chloroquine are received and validated by WHO.Between 31 March and 2 April 2020, the WHO SOLIDARITY trial, led by WHO, is reviewing potential treatments for COVID-19. Please refer to WHO medical product alert n°3/2020 for general information on falsified medical products in relation to the management of COVID-19.For photographs of products listed in Table 1, please refer to the WHO Medical Product Alert website, and to the annex of this medical product alert n°4/2020 (see pages 3-7).WHO requests increased vigilance within the supply chains of countries likely to be affected by these falsified products. Increased vigilance should include hospitals, clinics, health centres, wholesalers, distributors, pharmacies and any other suppliers of medical products.If you are in possession of the above products, please do not use. If you have used these falsified products, or if you suffer an adverse reaction/event having used these products, you are advised to seek immediate medical advice from a qualified healthcare professional, and to report the incident to the National Regulatory Authorities/National Pharmacovigilance Centre.All medical products must be obtained from licensed, authentic and reliable sources. Their authenticity and condition should be carefully checked. Seek advice from a healthcare professional in case of doubt.National regulatory/health authorities are advised to immediately notify WHO if these falsified products are discovered in their country. If you have any information concerning the manufacture, distribution, or supply of these products, please contact: rapidalert@who.int. WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical ProductsFor more information, please visit: www.who.int/medicines/regulation/ssffc/en/ Annex: Photographs of falsified chloroquine products circulating in the WHO region of Africa, Medical Product Alert N°4/2020CAMEROONPhotographs of confirmed falsified Chloroquine Phosphate (100mg)Photographs of confirmed falsified Chloroquine Phosphate (250mg)Photographs of confirmed falsified Chloroquine Phosphate 250mgDEMOCRATIC REPUBLIC OF CONGOPhotographs of confirmed falsified CLOROQUINE 250MGPhotographs of confirmed falsified Chloroquine Phosphate 250mgNIGERPhotographs of confirmed falsified Samquine 100 (100mg)Photographs of confirmed falsified Chloroquine phosphate tablets B.P 100mgPhotographs of confirmed falsified Niruquine (100mg)
Medical Product Alert N°4/2020
More from All WHO newsMore posts in All WHO news »